Gerbil Biological Reagents: A Tool for ADME and Metabolic Stability in the Drug Development and Pharmacokinetic Studies

Key words: ADME, In Vitro Metabolism, Metabolic Stability, Microsomal Stability, Hepatocyte Stability, Plateable Gerbil Hepatocyte, Suspension Gerbil Hepatocytes, Gerbil Liver Microsomes, Gerbil Liver S9 Fraction, Gerbil Plasma, Gerbil Serum, Gerbil PBMC
1 IPHASE Products

2 Marketing and Research Status of Gerbil Animal Remedy

The market for gerbil-specific animal remedies and drugs is significantly smaller compared to those for more common companion animals like dogs and cats, largely because gerbils are less frequently kept as primary pets and are often used as specialized experimental animal models. However, research involving gerbils has carved out important niches due to their unique susceptibilities, such as spontaneous epileptiform seizures, diet-induced diabetes, and their particular auditory system, making them valuable for neurological and hearing-related drug research. While a broad "gerbil pharmaceutical market" as a standalone entity is limited, their use in these specialized research areas drives demand for high-quality biological reagents and custom drug development.

3 Plateable Gerbil Hepatocyte and Suspension Gerbil Hepatocytes

For robust In Vitro Metabolism and Metabolic Stability assessments, various Gerbil-derived cellular and subcellular fractions are indispensable.

Plateable Gerbil Hepatocytes offer an adherent primary cell culture model, enabling long-term studies of drug metabolism and hepatotoxicity, critical for evaluating hepatocyte stability and robust in vitro metabolism assessments in a controlled environment. Complementing this, Suspension Gerbil Hepatocytes provide a versatile system for rapid intrinsic clearance measurements and metabolite identification in high-throughput screening, also valuable for assessing Hepatocyte Stability.

4 Gerbil Liver Microsomes

Gerbil microsomes are subcellular fractions rich in Phase I metabolic enzymes, widely utilized for initial drug metabolism and Metabolic Stability assessments. Gerbil Liver Microsomes are extensively used for Microsomal Stability assays, focusing on hepatic Phase I metabolic reactions and understanding drug clearance.

5 Gerbil Liver S9 Fraction

Gerbil S9 fractions are the supernatant of tissue homogenate after centrifugation at 9000g, which containing both microsomal (Phase I) and cytosolic (Phase II) metabolic enzymes, offering a more comprehensive in vitro system for drug metabolism profiling. Gerbil Liver S9 Fraction provides a complete enzymatic environment, essential for elucidating complex drug metabolic routes and assessing Metabolic Stability.

6 Gerbil Plasma and Gerbil Serum

Gerbil Plasma and Gerbil Serum are essential biological matrices for pharmacokinetic studies, allowing for accurate quantification of drug concentrations over time and assessing systemic exposure. These components are vital for correlating in vitro findings with in vivo drug behavior, forming a critical part of ADME characterization. Reliable data from Gerbil Plasma and Gerbil Serum samples are fundamental for building comprehensive ADME profiles, supporting effective.

7 Gerbil PBMC

Gerbil PBMC are a mixed population of immune cells isolated from whole blood, including lymphocytes, monocytes, and dendritic cells. These cells are essential for in vitro immunological studies, enabling researchers to assess drug effects on immune responses, cytokine production, and overall immune cell function. Gerbil PBMC are particularly useful when studying immune responses in models unique to gerbils, supporting the drug development process by providing insights into immunomodulatory effects.